dd
1. Gilead Sciences
GILD
Biotech giant Gilead, maker of 11 commercially available medicines for patients with life-threatening diseases, had a quiet but fruitful year. It has capitalized on the success of its most recently approved drug Atripla, a once-daily tablet for HIV patients, and its 2006 acquisition of pharmaceutical ingredient maker Raylo Chemicals. It's No. 1 on our list, but also one of the biggest gainers in the ranking: Last year, it was ranked 18th.
Current stock price: $43.32
Fair value estimate: $45.00
Related Links
tech highlight
, popular guide
, company
, growth
, top
, tech industry
, technology